Trimeris to Release Third Quarter 2008 Financial Results on Thursday, November 6, 2008.(Financial report)

DURHAM, N.C. -- Trimeris, Inc. (Nasdaq: TRMS) today announced that it will release its financial results for the third quarter 2008 on Thursday, November 6, 2008 at 7:30 a.m. Eastern Time. Trimeris' announcement will be followed by a conference call at 8:30 a.m., led by Mr. Martin A. Mattingly, Chief Executive Officer, and other members of senior management.

Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to members of the news media, investors and the general public. The webcast can be accessed by going to Trimeris' website, www.trimeris.com.

Conference Call

To access the live call, please dial (800) 399-8403 (U.S.) or (706) 634-6565 (international). The conference ID number is 71138027. Telephone replay is available approximately two hours after the call through 11:59 p.m. Eastern Time, November 20, 2008. To access the replay, please call (800) 642-1687 (U.S.) or (706) 645-9291 (international). The information provided on the teleconference is only accurate at the time of the conference call, and Trimeris will take no responsibility for providing updated information.

About Trimeris, Inc.

Trimeris, Inc. (Nasdaq: TRMS) is a biopharmaceutical company engaged in the commercialization of therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. FUZEON, approved in the U.S., Canada and European Union, is the first in a new class of anti-HIV drugs called fusion inhibitors. For more information about Trimeris, please visit the Company's website at http://www.trimeris.com.